- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens sells $16 million in PACS
The PACS division of Siemens Medical Systems in Iselin, NJ, roared through spring by landing PACS contracts in March worth a total of $16 million. The biggest purchaser is Saint Barnabas Medical Center in Livingston, NJ, which will spend more than $11
The PACS division of Siemens Medical Systems in Iselin, NJ, roared through spring by landing PACS contracts in March worth a total of $16 million. The biggest purchaser is Saint Barnabas Medical Center in Livingston, NJ, which will spend more than $11 million in a four-phase project that will convert the site to filmless operation.
In other big PACS sales, St. John's Hospital in Springfield, IL, is spending $1.6 million to expands its PACS network, while University Health System in San Antonio will be installing $1.4 million worth of PACS technology to provide digital image distribution for several modalities. Another client, University of Michigan Hospital in Ann Arbor, will spend $1 million on digital image management. Finally, Baylor Medical Center in Irving, TX, will be investing an additional $1 million to expand its filmless outpatient center at its North Campus.
In other Siemens PACS news, the company this month introduced MagicView 300, a Windows NT-based software package that can provide image distribution, teleradiology, and archiving capabilities. Siemens expects that both radiologists and clinicians will be users of the product.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
